他汀类药-话题@MedSci

#他汀类药#

345篇内容 | 4353人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2044653, encodeId=feec20446539d, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JAMA子刊：在肾衰竭伴外周动脉疾病(PAD)的患者中，他汀类药物治疗能改善心血管和肢体结局！, objectType=article, longId=739122, objectId=40e6e391227d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e6e391227d, replyNumber=0, likeNumber=187, createdTime=2023-01-01, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e6e391227d, moduleTitle=JAMA子刊：在肾衰竭伴外周动脉疾病(PAD)的患者中，他汀类药物治疗能改善心血管和肢体结局！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e6e391227d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044652, encodeId=17d8204465252, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响, objectType=article, longId=737622, objectId=1a68e376228d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a68e376228d, replyNumber=0, likeNumber=116, createdTime=2023-03-29, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a68e376228d, moduleTitle=Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a68e376228d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044647, encodeId=4907204464e6f, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JACC：既往他汀类药物治疗对急性冠脉综合征患者急性心衰和死亡风险的影响, objectType=article, longId=727967, objectId=193ee27967e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=193ee27967e7, replyNumber=0, likeNumber=177, createdTime=2023-03-28, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=193ee27967e7, moduleTitle=JACC：既往他汀类药物治疗对急性冠脉综合征患者急性心衰和死亡风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=193ee27967e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044645, encodeId=5ee72044645c0, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=BMC Cancer：他汀类药物治疗可能可增加NSCLC使用免疫治疗的疗效, objectType=article, longId=727629, objectId=81f5e2762915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81f5e2762915, replyNumber=0, likeNumber=126, createdTime=2023-02-05, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81f5e2762915, moduleTitle=BMC Cancer：他汀类药物治疗可能可增加NSCLC使用免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81f5e2762915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044646, encodeId=819a204464696, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响, objectType=article, longId=727775, objectId=9479e277750a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9479e277750a, replyNumber=0, likeNumber=123, createdTime=2022-06-21, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9479e277750a, moduleTitle=Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9479e277750a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044650, encodeId=8bc22044650a1, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Neurology：长期使用他汀类药物与脑内出血风险的关系: 丹麦全国病例对照研究, objectType=article, longId=730587, objectId=958de30587af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=958de30587af, replyNumber=0, likeNumber=121, createdTime=2022-11-03, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=958de30587af, moduleTitle=Neurology：长期使用他汀类药物与脑内出血风险的关系: 丹麦全国病例对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=958de30587af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044640, encodeId=6d8f2044640cd, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Circulation：他汀类药物用于心血管疾病的预防，获益不止10年！, objectType=article, longId=301152, objectId=092830115250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=092830115250, replyNumber=0, likeNumber=129, createdTime=2022-12-03, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=092830115250, moduleTitle=Circulation：他汀类药物用于心血管疾病的预防，获益不止10年！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=092830115250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044636, encodeId=d0f3204463673, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JAMA Netw Open：他汀类药物治疗高危高甘油三酯血症患者的成本-效果分析, objectType=article, longId=299396, objectId=be8629939660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be8629939660, replyNumber=0, likeNumber=113, createdTime=2022-10-06, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be8629939660, moduleTitle=JAMA Netw Open：他汀类药物治疗高危高甘油三酯血症患者的成本-效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be8629939660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044641, encodeId=d95f20446414d, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=BMJ：不同他汀类药物对糖尿病患者非高密度脂蛋白胆固醇(non-HDL-C) 水平以及心血管疾病风险的影响, objectType=article, longId=301851, objectId=88de3018519b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88de3018519b, replyNumber=0, likeNumber=153, createdTime=2022-04-10, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88de3018519b, moduleTitle=BMJ：不同他汀类药物对糖尿病患者非高密度脂蛋白胆固醇(non-HDL-C) 水平以及心血管疾病风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88de3018519b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044648, encodeId=f5e420446482c, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle= Invest Dermatol:他汀类药物治疗银屑病的黄金时期要来了？, objectType=article, longId=728033, objectId=f467e2803321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f467e2803321, replyNumber=0, likeNumber=162, createdTime=2023-03-10, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f467e2803321, moduleTitle= Invest Dermatol:他汀类药物治疗银屑病的黄金时期要来了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f467e2803321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044639, encodeId=00b4204463904, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JAMA子刊：真那么神吗？他汀类药物治疗降低死亡、心肌梗死及中风的发生率分析, objectType=article, longId=300865, objectId=9250300865cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9250300865cd, replyNumber=0, likeNumber=143, createdTime=2022-08-17, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9250300865cd, moduleTitle=JAMA子刊：真那么神吗？他汀类药物治疗降低死亡、心肌梗死及中风的发生率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9250300865cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044654, encodeId=107a204465448, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？, objectType=article, longId=739416, objectId=539be394168c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=539be394168c, replyNumber=0, likeNumber=110, createdTime=2023-04-27, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=539be394168c, moduleTitle=JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=539be394168c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044643, encodeId=229120446432c, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系, objectType=article, longId=724173, objectId=af7ee2417375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af7ee2417375, replyNumber=0, likeNumber=154, createdTime=2023-03-14, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af7ee2417375, moduleTitle=Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af7ee2417375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044638, encodeId=0a662044638fa, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=DCR：他汀类药物治疗与结肠癌手术后 90 天术后死亡率降低有关, objectType=article, longId=300764, objectId=e1ab300e640c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ab300e640c, replyNumber=0, likeNumber=181, createdTime=2022-11-28, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ab300e640c, moduleTitle=DCR：他汀类药物治疗与结肠癌手术后 90 天术后死亡率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ab300e640c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044642, encodeId=4545204464228, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Neurology：他汀类药物或由较低几率的大脑动脉粥样硬化介导，可降低成年人患帕金森综合征风险！, objectType=article, longId=301702, objectId=8e3c301e0220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3c301e0220, replyNumber=0, likeNumber=0, createdTime=2022-04-19, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3c301e0220, moduleTitle=Neurology：他汀类药物或由较低几率的大脑动脉粥样硬化介导，可降低成年人患帕金森综合征风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3c301e0220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044644, encodeId=28622044644e1, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Eur J Cancer：二甲双胍和他汀类药物对转移性去势抵抗性前列腺癌患者预后的影响, objectType=article, longId=727118, objectId=4bc9e2711830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bc9e2711830, replyNumber=0, likeNumber=171, createdTime=2022-11-23, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bc9e2711830, moduleTitle=Eur J Cancer：二甲双胍和他汀类药物对转移性去势抵抗性前列腺癌患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bc9e2711830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044651, encodeId=7f59204465166, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=CGH: 急性胰腺炎后他汀类药物使用与糖尿病发展的关系, objectType=article, longId=730557, objectId=cb8be3055725, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb8be3055725, replyNumber=0, likeNumber=153, createdTime=2023-06-10, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb8be3055725, moduleTitle=CGH: 急性胰腺炎后他汀类药物使用与糖尿病发展的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb8be3055725)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044632, encodeId=a5f5204463200, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=J Clin Lipidol：在接受他汀类药物治疗的冠心病患者中，较低的LDL-C水平与较低的薄纤维帽粥样斑块发生率相关, objectType=article, longId=293581, objectId=6e4c293581c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4c293581c4, replyNumber=0, likeNumber=157, createdTime=2022-01-17, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4c293581c4, moduleTitle=J Clin Lipidol：在接受他汀类药物治疗的冠心病患者中，较低的LDL-C水平与较低的薄纤维帽粥样斑块发生率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e4c293581c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044637, encodeId=72f7204463e02, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=Cardiovasc Diabetol ：他汀类药物强度、达到的低密度脂蛋白胆固醇水平和他汀类药物治疗时间对降低2型糖尿病患者心血管风险的相对贡献, objectType=article, longId=300114, objectId=26af30011480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26af30011480, replyNumber=0, likeNumber=157, createdTime=2022-07-22, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26af30011480, moduleTitle=Cardiovasc Diabetol ：他汀类药物强度、达到的低密度脂蛋白胆固醇水平和他汀类药物治疗时间对降低2型糖尿病患者心血管风险的相对贡献, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26af30011480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044649, encodeId=79f820446492b, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, objectTitle=JAHA：他汀类药物进行心血管疾病一级预防与COVID-19住院之间的相关性, objectType=article, longId=729669, objectId=a08ce2966940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a08ce2966940, replyNumber=0, likeNumber=123, createdTime=2023-02-05, rootId=0, userName=ms6390871039024434, userId=f8672500006, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a08ce2966940, moduleTitle=JAHA：他汀类药物进行心血管疾病一级预防与COVID-19住院之间的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a08ce2966940)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

他汀类药

2020-05-29

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JAMA子刊：在肾衰竭伴外周动脉疾病(PAD)的患者中，他汀类药物治疗能改善心血管和肢体结局！

2023-01-01

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Cardiovasc Diabetol：在他汀类药物治疗的糖尿病患者中，LDL-C状态对冠状动脉钙化积分增加和成分斑块体积进展之间关系的影响

2023-03-29

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JACC：既往他汀类药物治疗对急性冠脉综合征患者急性心衰和死亡风险的影响

2023-03-28

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

BMC Cancer：他汀类药物治疗可能可增加NSCLC使用免疫治疗的疗效

2023-02-05

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响

2022-06-21

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Neurology：长期使用他汀类药物与脑内出血风险的关系: 丹麦全国病例对照研究

2022-11-03

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Circulation：他汀类药物用于心血管疾病的预防，获益不止10年！

2022-12-03

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JAMA Netw Open：他汀类药物治疗高危高甘油三酯血症患者的成本-效果分析

2022-10-06

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

BMJ：不同他汀类药物对糖尿病患者非高密度脂蛋白胆固醇(non-HDL-C) 水平以及心血管疾病风险的影响

2022-04-10

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Invest Dermatol:他汀类药物治疗银屑病的黄金时期要来了？

2023-03-10

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JAMA子刊：真那么神吗？他汀类药物治疗降低死亡、心肌梗死及中风的发生率分析

2022-08-17

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？

2023-04-27

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Stroke：β受体阻滞剂或他汀类药物使用与海绵状畸形出血风险之间的关系

2023-03-14

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

DCR：他汀类药物治疗与结肠癌手术后 90 天术后死亡率降低有关

2022-11-28

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Neurology：他汀类药物或由较低几率的大脑动脉粥样硬化介导，可降低成年人患帕金森综合征风险！

2022-04-19

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Eur J Cancer：二甲双胍和他汀类药物对转移性去势抵抗性前列腺癌患者预后的影响

2022-11-23

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

CGH: 急性胰腺炎后他汀类药物使用与糖尿病发展的关系

2023-06-10

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

J Clin Lipidol：在接受他汀类药物治疗的冠心病患者中，较低的LDL-C水平与较低的薄纤维帽粥样斑块发生率相关

2022-01-17

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

Cardiovasc Diabetol ：他汀类药物强度、达到的低密度脂蛋白胆固醇水平和他汀类药物治疗时间对降低2型糖尿病患者心血管风险的相对贡献

2022-07-22

ms6390871039024434 (审核中...)

前往app查看评论内容

#他汀类药#

JAHA：他汀类药物进行心血管疾病一级预防与COVID-19住院之间的相关性

2023-02-05

科室
- - 订阅+
  - 更多科室
工具
服务